Novel peptide inhibitors targeting CD40 and CD40L interaction: A potential for atherosclerosis therapy
Kundan Solanki1, Ashutosh Kumar2, Mohd Shahnawaz Khan3, Subramani Karthikeyan4, Rajat Atre1, Kam Y.J. Zhang2, Evgeny Bezsonov5,6,7, Alexander G. Obukhov8,9, Mirza S. Baig1
1Department of Biosciences and Biomedical Engineering (BSBE), Indian Institute of Technology Indore (IITI), Simrol, Indore, 453552, India
2Laboratory for Structural Bioinformatics, Center for Biosystems Dynamics Research, RIKEN, Tsurumi, Yokohama, Kanagawa, Japan
3Department of Biochemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia
4Centre for Healthcare Advancement, Innovation and Research, Vellore Institute of Technology University, Chennai Campus, Chennai, 600127, India
5Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 8 Baltiiskaya Street, 125315, Moscow, Russia
6Laboratory of Cellular and Molecular Pathology of Cardiovascular System, Avtsyn Research Institute of Human Morphology of Federal State Budgetary Scientific Institution “Petrovsky National Research Centre of Surgery”, 3 Tsyurupa Street, 117418, Moscow, Russia
7Department of Biology and General Genetics, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8 Izmailovsky Boulevard, 105043, Moscow, Russia
8Department of Anatomy, Cell Biology, & Physiology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
9Stark Neurosciences Research Institute, Indiana University School of Medicine, Indianapolis, IN, 46202, USA
Thông tin
Thông tin xuất bản
Current Research in Structural Biology
Tập 6
100110
Thông tin tác giả